Biomedical Engineering Reference
In-Depth Information
k 1 s C A 0
ð1 þ k 1 s Þð1 þ k 2 s Þ
C B ¼
(E5-8.14)
This maximum concentration of B (or the production rate of B) can be obtained by setting
s m ¼ ð 1 þ k 1 s m Þð 1 þ k 2 s m Þ s m ½ k 1 ð 1 þ k 2 s m Þþ k 1 ð 1 þ k 2 s m Þ
d C B
d
0 ¼
k 1 C A 0
(E5-8.15)
2
2
s
ð1 þ k 1 s m Þ
ð1 þ k 2 s m Þ
which gives the contact time required for maximum production of B in a CSTR
1
k 2 k 1
s m ¼
p
(E5-8.16)
and the corresponding concentration of B is given by
(E5-8.17)
s ! 2
k 2
k 1
C B max ¼ C A 0
1 þ
Figure E5-8.3 shows the ratio of the maximum concentration B in a PFR, Eqn (E5-8.10) to that
in a CSTR, Eqn (E5-8.17) , as a function of the kinetic rate constant k 2 / k 1 . One can observe that the
productivity to B is higher in a PFR than in a CSTR, as the ratio is always greater than unity.
Therefore, the optimum reactor type is PFR, with a contact time given by Eqn (E5-8.9) if the
desired product is the intermediate product B.
Example 5-8 shows that PFR is better suited for intermediate product production. This can be
easily interpreted from the concentration distributions. In a CSTR, the reactant concentration is
1.5
1.4
1.3
1.2
1.1
1.0
10 -4
10 -3
10 -2
10 -1
10 0
10 1
10 2
10 3
10 4
k/k
2
1
FIGURE E5-8.3 The ratio of the maximum intermediate product B in a PFR to that in a CSTR as a function of the
kinetic rate constant ratio.
Search WWH ::




Custom Search